Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00463840 · ClinicalTrials.gov registry record · Phase 1
Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer
A Phase 1 study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00463840 is a Phase 1 study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 24 participants.
The verdict
NCT00463840, a Phase 1 study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The intention of this trial is to determine the maximum tolerated of the treatment combination and to evaluate its safety and efficacy.
Interventions
- DRUG Oxaliplatin
- RADIATION Radiation
- PROCEDURE Surgery
- DRUG 5FU
- DRUG FOLFOX 6
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-06 |
| Est. Completion | 2015-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00463840
The ClinicalTrials.gov registry entry for NCT00463840 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Oxaliplatin is the first listed.
NCT00463840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00463840 about?
NCT00463840 is a clinical study titled "Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer". The intention of this trial is to determine the maximum tolerated of the treatment combination and to evaluate its safety and efficacy.
What is the current status of trial NCT00463840?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2004-06. Estimated completion is 2015-10.
What interventions are being tested in trial NCT00463840?
The interventions under investigation include: Oxaliplatin (DRUG), Radiation (RADIATION), Surgery (PROCEDURE), 5FU (DRUG), FOLFOX 6 (DRUG).
Who is sponsoring clinical trial NCT00463840?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.